Biochips market research report

RITMIR012: Biochips – A Market Insight Report, July 2013
© RI Technologies - www.researchimpact.com Sample Page - 1
BIO CHIPS MARKET SIZE
Scope of the Study
The report on Biochips gives an insight into the market for Biochips and Biochip Related Products. The
biochip related products include Biochip Instruments, Software, Reagents & Consumables, and Services.
The study provides global market analysis for Biochips by type and Biochip related products by their
application in Drug Discovery & Development, Genomics, Clinical Diagnostics, and Other applications
comprising Water and Environmental Testing, Forensics, and Identity Testing, etc. Depending upon the
biological material attached to the surface of the chip which can be glass, plastic or silicon, biochips are
classified into DNA, Protein, Lab-On-Chips and Other including Tissue biochips, and Carbohydrate biochips.
The study includes estimates and projections for the global biochips market. Projections and estimates are
also illustrated by geographic region encompassing North America, Europe, Japan, Asia-Pacific, and Rest of
World.
Business profiles of 35 major companies are discussed in the report. The report serves as a guide to global
biochips industry, as it covers more than 400 companies that are engaged in biochip R&D, discovery, testing
and supply of products and services. Major Contract Research Organizations and Universities serving
biochips industry are also covered in the Corporate Directory section of this report. Information related to
recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions
is also covered in the report.
Biochips report is an ideal research tool providing strategic business intelligence to the corporate sector.
This report may help strategists, investors, laboratories, pharmaceutical companies, contract research
organizations, biotechnology companies and drug approval authorities in-
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets
Analytics and data presented in this report pertain to several parameters such as -
 Global And Regional Market Sizes, Market Shares, Market Trends
 Product (Global And Regional) Market Sizes, Market Shares, Market Trends
 Technology Trends
 Corporate Intelligence
 Key Companies By Sales, Brands, Products
 Consumer Behavioral Patterns

 Other Strategic Business Affecting Data
Research Methodology
RI Technologies publishes business intelligence reports by going through a cycle of diligent research and
analysis activity. Research is done using both online and offline resources. The study outline of this report is
sketched on the following lines - global market analysis, regional market analysis, product segmentation,
global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape,
technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is
also helpful for doing market evaluations, and estimating the market size for the future.
This report is uniquely researched and the methodology includes:
 Need and Scope of Study
 Product Definitions
 Segmental Analysis
 Regional Analysis
 Exclusive Data Analytics
 Corporate Intelligence
 Feedback
Right from concept to final compilation of this report, both primary and secondary research methods are
applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the
information for authentication of our own findings. Secondary research includes government publications,
investment research reports, web based surveys, website information of both companies and markets, and
other offline resources such as print publications and CDs.
Our compilation of easy to navigate PDF reports are essential value addition resources for leading and
growing companies.

II. REPORT SYNOPSIS
Biochips
Biochip or gene micro array is a small square of glass embedded with millions of strands of DNA, produced
by using microlithography technique. Biochips were invented by gene scientist Stephen Fodor.
Development of biochip utilizes multiple technologies such as sensor technology, micro arraying, signal
processing, and biochemistry etc. The key part in the Biochip is the sensing component analysis system
which transducts the actual sensing event into computer language and then analyzes the result into
human-readable output. Multidisciplinary approach is regarded as the hindrance to the development of
Biochip. The first commercially available biochip “gene chip” was introduced by Affymetrix and is used to
detect genes related to tumors (p53) and breast cancer (BRCA1and BRCA2).
A biochip is a combination of micro fabrication technology and life sciences in a miniaturized device. Small
enough to fit the palm of the hand the so-called "lab on a chip" or micro total analysis systems (µTAS)
employs miniaturization of biological separation and assay techniques to an extent that multiple and
complex analyses can be done on a chip.
Fundamentally, biochips are computer-chip look-alikes intended to speedily, reliably, and inexpensively
perform biochemical procedures that together constitute a medical test. The far slower, more
cumbersome, more expensive laboratory equipment can be replaced by their miniaturization and
automation of laboratory procedures
Their current applications lie principally in the analysis of genes for defects or sequence variations. They
may soon facilitate screening of molecules for potential usefulness as drugs. The immediate goal is to
enable them to serve point-of-care diagnosis.
Biochips are similar to semiconductors, except that instead of having electronic circuits, they have
biological material, DNA or RNA or protein, attached to the substrate which can be glass, plastic or silicon.
A biochip is a collection of miniaturized test sites arranged on a solid substrate that permits many tests to
be performed at the same time, in order to achieve higher throughput and speed. Surface area comparable
to that of human finger nail has the potential to perform many biological reactions like decoding the genes,
like a computer chip which can perform millions of mathematical operations in seconds.
Thus, biochips may be regarded as engineered systems that effectively bring together three important and
dominant technologies of the 20th century - microelectronics, biotechnology and information technology.
Segmentation of Biochips
Exhibit 1. Segmentation of Biochips Market by Type, Application, and by Related Products
Type Application Related Products
Dna Drug Development Instruments
Protein Genomics Software
Lab-On-Chip Clinical Diagnosis Reagents And Consumables
Cellular Other Services
Other
© RIT, 2013

Global Market Analysis
Global biochips market is projected to reach about US$ XX.XX billion by 2020 from a market of US$ XX.XX
billion in 2012, growing at a compounded annual growth rate (CAGR) of XX.XX % during the analysis period
2005-2020.
Exhibit 2. Biochips - Global Value Market Estimations & Predictions (2005-2020) in US$ Million
Year Value
2005 XX.XX
2006 XX.XX
2007 XX.XX
2008 XX.XX
2009 XX.XX
2010 XX.XX
2011 XX.XX
2012 XX.XX
2013 XX.XX
2014 XX.XX
2015 XX.XX
2016 XX.XX
2017 XX.XX
2018 XX.XX
2019 XX.XX
2020 XX.XX
CAGR% XX.XX
© RIT Figures, 2013
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
US$ Million

Biochips and Biochip Related Products
Global biochip related products market is projected to reach about US$ XX.XX billion by 2020 from a market
of US$ XX.XX billion in 2012. The market is projected to grow at a compounded annual growth rate (CAGR)
of XX.XX % during the analysis period 2005-2020.
Exhibit 3. Biochips and Biochip Related Products - Global Value Market Estimations & Predictions (2005 -
2020) in US$ Million
Year Value
2005 XX.XX
2006 XX.XX
2007 XX.XX
2008 XX.XX
2009 XX.XX
2010 XX.XX
2011 XX.XX
2012 XX.XX
2013 XX.XX
2014 XX.XX
2015 XX.XX
2016 XX.XX
2017 XX.XX
2018 XX.XX
2019 XX.XX
2020 XX.XX
CAGR % XX.XX
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
US$ Million

III. MARKET DYNAMICS
Market Overview
Biochips have become an integral part in the process of drug discovery since the last few years. Biochips
market in the global arena is on an upward swing. Biochips which save time in target identification and
consequently reduce R & D costs significantly are a boon to drug manufacturing industries. New drug
research uses biochips for drug assays and also to test them for toxicity. This is done so that fewer, or
perhaps eventually, no animal testing needs to be done. The concept of personalized medicine is also
driving the growth of the demand for biochip.
A positive regulatory swing towards use of biochips is anticipated, which may decrease the drug’s time to
market and eventually increase monetary inflows.
Biochips are playing a key role in clinical diagnosis i.e. they help in diagnosis of disease even before the
symptoms are observed Biochips which can identify the presence of different proteins, Nucleic acids,
different bacteria etc. in a single analysis help to diagnose the disease.
Global Market Analysis
Global market for biochips and biochip related products is projected to reach about US$ XX.XX billion by
2020 from a reported value of US$ XX.XX billion in 2012 growing at a Compounded Annual Growth Rate
(CAGR) of XX.XX % during the analysis period, 2005-2020. Global Biochips and biochip related products
market for 2012 is estimated at US$ XX.XX billion.
Biochips accounted for the largest share in the global biochips and biochip related products in 2012 with a
share of XX.XX % valued at US$ XX.XX billion and is projected to reach US$ XX.XX billion by 2020 to retain its
leading position with a share of XX.XX %.
Instruments is projected to be the second largest (XX.XX % market share in 2020) market. Services are the
fastest growing market with growth rate of XX.XX %.

Exhibit 4. Biochips and Biochip Related Products (2005-2020) - Global Market Analysis (Current & Future)
for Biochips, Instruments, Software, Reagents and Consumables and Services in US$ Million
Year/Products Biochips Instruments Software Reagents & Consumables Services Total
2005 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX
CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
US$ Million
Biochips Instruments Software Reagents& Consumables Services

BIOCHIPS - THE INDUSTRY OUTLOOK
Global Biochips market is projected to grow at 21.82% compounded annually from 2005 through 2020. This
growth would be driven especially by application of biochips in Clinical Diagnostics, Drug Development.
Biochips are expected to increase the number of drugs released by reducing the time involved in the drug
development process, leading to savings in time and costs. Biochips are becoming an essential part of drug
discovery process, bolstering efficiency and accuracy.
The North America, the leading market (49.1% of global market share in 2006) for biochips presently is
projected to manage the leading position throughout the analysis period with its share dropping to 46.48%
by 2012. Due to the cost advantage and access to the latest technology, Asia-Pacific is emerging as the
fastest growing (23.42% during 2005-2012) market for biochips. This region is potentially well poised to lay
a significant role in development of biochips in the near future. Europe and Japan are expected to gain
market shares while the North America may lose market dominance.
IV. PRODUCT/TECHNOLOGY RESEARCH
The biotechnology industry is growing at an astonishingly rapid rate. The development of biochips has
brought incalculable changes to it .The influence of this percolates into other streams of knowledge such as
genomics, pharmaceuticals, computational biology, and proteomics. These new developments are giving
hope to research scientists to look into the intricate biochemical processes that takes place inside the
confines of cells. The research studies have a goal to reach in the upliftment of mankind through the
eradication of diseases which plague human society. The semiconductor industry has been steadily
perfecting the science of microminiaturization. The merging of these two fields in recent years has enabled
biotechnologists to begin packing their traditionally bulky sensing tools into smaller and smaller spaces;
onto so-called the world of biochips is opening new vistas into diverse fields from the diagnosis of diseases
to combating bioterrorism. Screening of a large number of determinants is being analyzed at the shortest
of time.
Biotechnology is believed to have immense potential to bring about great changes. The research into the
biochemical functions of cells, genes and proteins in the body of man is assuming a role of bringing solace
to people. Through early diagnosis of diseases, targeting the right medicine in the right dose depending on
the genetic makeup of the individual and even being able to identify the allergens by means of simple
biochemical analyses. The majority of microarrays are presently comprised of glass or plastics which is
designed in such a fashion that it is detected by optical sensors. Now the revolutionary concept is to usher
in semiconductor chips that are combined with biology. This will open up new pathways for the
advancement of science in the future.
The concept of a computer chip which is low cost and at the same time reliable, appearing in all respects
like a computer chip is no doubt a captivating proposition. Through this we see miniaturization, automation
and acceleration of time consuming procedures involving bulky laboratory equipments. Apart from this the
cost factor is quite favorable when compared with traditional methods. The uses of this new concept will

be to analyze genetic material to pin point the inherent defects, to investigate the sequence variations for
purposes of diagnosis, forensics and therapeutics. Biological fluids could also be analyzed for diagnostic and
therapeutic conclusions. A study of intermolecular interactions with the specific goal of drug lead screening
is also a noteworthy potentiality.
Another area which will be benefited is the assay chemistry of micro fluids. The minutest volume of liquids
could be investigated and ultra-sensitive detections will be made possible. The advance in chip
manufacturing processes for the exclusive use of bio-assay purposes is all set to bring in a complete
radicalization in the developments in this field. Large corporate bodies are already evincing keen interest in
the vast potential of biochips. They would like to use it as a point-of-care tool for diagnosis. They also
intend to utilize it as a throughput screening platform for investigative drug lead identification. Researchers
are putting maximum effort in developing a standardized chip platform that can find universal application
similar to the modern day computer chips.
DNA micro array a form of the biochip has revolutionalized biological enquiry This will eventually lead to
simultaneous assessment of the various levels of gene expression, polymorphism and functional genomics
also known as transcriptomic variation. This could all be accomplished experimentally while undertaking a
complete survey of the genome in a particular organism. The main evolutionary consequence of the DNA
microarray is the prognostic or more pointedly the diagnostic value of the biochip. Molecular biology has
been revolutionized by DNA microarray. Now we are about to witness how the biochip is going to
revolutionize molecular diagnostics. Broadly speaking the biochip is a measuring device that has a built-in
recognition component. It could also work with devices that use the traditional techniques of
microlithography and microarraying technologies. Biochips are similar to biosensors and only differ in the
use of microlithography fabrication techniques in their production. Biochips are made up of microarrays
which have high, medium or low density bioelectronics chips and capillary agarose chips. In short it is
observed that microarrays are biochips but all biochips are not microarrays.
If looked at from another point of view we could describe the biochip as an engineered device or system
having a chip component and a biologically derived component. Thus we see that in this simplistic theory
there lies a dominant theme which will capture the imagination of man in the 21st century. This theme
brings together the three major juggernauts of the 20th century namely microelectronics, biotechnology
and information technology. These technologies are wide and varied and converge to form a new union.
The chip substrate may appear to be as simple as the glass slide of a microscope or it could project itself as
complex as a fully integrated microfluidic system having association with microelectronics and MEMS
devices. The biologically derived component could be molecular, organelle, cellular or even tissue based.
The biologically derived component may be molecular (enzymes, antibodies, DNA), organelle
(mitochondria, cell wall), cellular (neuronal cells, islet cells), or tissue (liver slices) based. With this diversity
of options, biochips have emerged as a major field of study, active product development and commercial
activity
About RI Technologies
RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We
emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly
monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry
based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging
technologies in areas of discovery, design and development.

Research – As Good as the Methodology is!
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets
© COPYRIGHT
The copyright and publication rights to all RI Technologies' reports and other products are the property of
the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of
the material without express permission is not allowed. The buyer, under no circumstances, shall license,
resell or repackage, or sell data without prior permission of the company.
DISCLAIMER
RI Technologies sells content in good faith. The company is not liable to the buyer for any implications
arising out of the usage of data for any particular purpose. The company makes no representations or
warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for
data compilation and presentation, the company does not accept any responsibility for findings in the study
which are a cumulative effort of primary and secondary research resources. The studies do not endorse or
promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are
not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage
of the data.

Biochips market research report

Recomendados

Recomendados

Mais conteúdo relacionado

Mais de Research Impact

Mais de Research Impact (10)

Último

Último (20)

Biochips market research report